Warsaw, Poland

Piotr Skibicki



Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • ul. Waszyngtona 39m.24, PL (1997)
  • Warsaw 04015, PL (2002)
  • Warsaw, PL (2004 - 2009)

Company Filing History:


Years Active: 1997-2009

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Piotr Skibicki

Introduction

Piotr Skibicki is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anthracycline antibiotics. With a total of 5 patents to his name, Skibicki's work has the potential to impact cancer treatment significantly.

Latest Patents

Skibicki's latest patents focus on anthracycline antibiotics and methods of treating cancer. One of his inventions discloses new and novel substituted anthracyclines with modified alkyl-aromatic ring substitutions on the C-3' of the sugar moiety. It also details methods for preparing sugar substrates and anthracycline antibiotics. These anthracycline analogs demonstrate high cytotoxicity in vitro against several tumor cell lines, showcasing their potential effectiveness in cancer therapy.

Career Highlights

Throughout his career, Piotr Skibicki has worked with various organizations, including Houston Pharmaceuticals, Inc. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of cancer treatment.

Collaborations

Skibicki has collaborated with notable professionals in his field, including Roman Perez-Soler and Waldemar Priebe. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Piotr Skibicki's innovative work in the development of anthracycline antibiotics positions him as a significant figure in the fight against cancer. His contributions through his patents reflect a commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…